Spensus Pharmaceuticals Private Limited

Spensus Pharmaceuticals Private Limited - pharma in Kadi, Gujarat, India. FY 2026 financials and compliance.
CIN U74999GJ2018PTC100978 Incorporated 24 February 2018 ROC Ahmedabad HQ Kadi, Gujarat, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2024
₹5.59 Cr
▲ 48995.00% YoY
EBITDA · FY 2024
Locked
In full report
Net profit · FY 2024
Locked
In full report
Authorised capital
₹6 Cr
Registered with MCA
Paid-up capital
₹5.2 Cr
Issued & subscribed
Open charges
₹17.98 Cr
Secured borrowings
Company age
8 yrs
Est. 2018
Employees · EPFO
4
Latest available

About Spensus Pharmaceuticals Private Limited

Data last updated: 18 December 2025

Spensus Pharmaceuticals Private Limited is a private limited company based in Kadi, Gujarat, India, recognised as a startup by DPIIT. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 24 February 2018, the company has been in operation for over 8 years.

Registered with ROC Ahmedabad under CIN U74999GJ2018PTC100978.

Capital: an authorised share capital of ₹6 Cr and a paid-up capital of ₹5.2 Cr. It is led by directors Nileshkumar Haribhai Patel and Tanmay Natvarbhai Patel.

Last AGM: 30 September 2024. Financial statements filed for year ended 31 March 2024. Office: Kadi, Gujarat.

As per the financials filed for FY 2024, the company reported a revenue of ₹5.59 Cr, reflecting significant growth compared to the previous year.

The company has a workforce of approximately 4 employees as per the latest available data.

The company is associated with 2 brands - Spensus Pharma, Ambix Healthcare Llp. As per MCA filings, the company has open charges of ₹17.98 Cr on record.

For more details, the company can be reached via its website spensuspharma.com.

Company Details of Spensus Pharmaceuticals Private Limited
CIN U74999GJ2018PTC100978
Registration Number 100978
Incorporation Date 24 February 2018
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
DPIIT Recognition Recognised Startup
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Social Media
    Locked
  • Registered Address
    Unit No.1 Survey No.284 B/H Honest Hotel Dhanali Road Ahmedabad – Mehsana Highway G, Aneshpura, Kadi, Gujarat, India – 382705
  • Industry
    Pharma, Drug Formulation & Development
Company report
Spensus Pharmaceuticals Private Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Spensus Pharmaceuticals Private Limited report

Financials, compliance, directors, charges, ownership and filings for Spensus Pharmaceuticals Private Limited in one report.

10-year financials Directors & ownership Charges & compliance

Associated Brands with Spensus Pharmaceuticals Private Limited

Spensus Pharmaceuticals Private Limited operates two associated brands: SPENSUS Pharma and Ambix Healthcare LLP. These brands represent Spensus Pharmaceuticals Private Limited's diversified market presence and brand portfolio.

Brand Description Website
Develops, manufactures, and markets pharmaceutical formulations worldwide. spensuspharma.com
Indian company developing, manufacturing, and exporting pharmaceutical products globally. ambixhealthcare.com

Competitors & Alternatives of Spensus Pharmaceuticals Private Limited

Brands and companies operating in the same space as Spensus Pharmaceuticals Private Limited include Pharmaron, Pfizer, Lonza and 7 more.

Competitor Description Location Founded
Pharmaron Pharmaron Drug discovery and development services for small molecules are provided. Beijing, China, China 2003
Pfizer Pfizer Pharmaceutical products for treating multiple diseases are provided. New York, United States, United States 1849
Lonza Lonza CDMO services for pharma, biotech, and specialty ingredients are provided. Basel, Switzerland, Switzerland 1897
Dotmatics Dotmatics AI powered scientific data management and workflow automation solutions - 2005
Boehringer Ingelheim Boehringer Ingelheim Generic drugs and clinical research services are provided globally. - 1885
LabConnect LabConnect Laboratory testing, clinical trial research, and biopharma services are provided. Johnson City, United States, United States 2002
Beta Drugs Beta Drugs Developer of therapeutics for oncology and dermatology Panchkula, India, India 2005
Zevra Zevra Marketing services are provided to biopharma companies. Celebration, United States, United States 2006
Sayre Therapeutics Sayre Therapeutics Access to therapies for rare and life-threatening diseases is provided. Bengaluru, India, India 2015
Ainos Ainos Novel point-of-care testing and low-dose interferon therapeutics are developed. San Diego, United States, United States 1986

Business Activity of Spensus Pharmaceuticals Private Limited

Spensus Pharmaceuticals Private Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
C Manufacturing C6 Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products Locked
Premium access

Business activity turnover details for Spensus Pharmaceuticals Private Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Spensus Pharmaceuticals Private Limited

Spensus Pharmaceuticals Private Limited is audited by MUKESH P. PATEL & CO. for the financial year 2024. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
MUKESH P. PATEL & CO. Locked Locked Locked
Premium access

Complete auditor history for Spensus Pharmaceuticals Private Limited

Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Spensus Pharmaceuticals Private Limited

Spensus Pharmaceuticals Private Limited is currently managed by 2 directors, with 3 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Nileshkumar Haribhai Patel Director 24 Feb 2018 8 Years 5 Months Current
Tanmay Natvarbhai Patel Director 24 Feb 2018 8 Years 5 Months Current

Financials of Spensus Pharmaceuticals Private Limited FY 2024 filings available

Spensus Pharmaceuticals Private Limited reported revenue of ₹5.59 Cr (up 48995.00% YoY) for FY 2024.

Revenue · FY 2024
₹5.59 Cr ▲ 48995.00%
Premium access

Ten-year financial statements for Spensus Pharmaceuticals Private Limited

Historical statement values and trend charts require an active report plan.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Spensus Pharmaceuticals Private Limited

Premium access

Shareholding and ownership data for Spensus Pharmaceuticals Private Limited

Promoter, institutional, public, and beneficial ownership values require an active report plan.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Spensus Pharmaceuticals Private Limited

Open charges
₹17.98 Cr
Satisfied charges
₹0
Breakdown by lending institutions
Sidbi₹17.98 Cr
Latest charge details
DateLenderAmountStatus
27 Aug 2024 Sidbi ₹3.48 Cr Open
13 Jan 2022 Sidbi ₹9 Cr Open
13 Jan 2022 Sidbi ₹5 Cr Open
13 Jan 2022 Sidbi ₹50 Lakh Open

Total charge records: 4 View all charges

Employees and EPFO Compliance at Spensus Pharmaceuticals Private Limited

Spensus Pharmaceuticals Private Limited has a workforce of 4 employees as of Mar 26, 2025.

Employee count
4
Active EPFO establishments
1
Employee growth
33.33%
Premium access

Employee and EPFO history for Spensus Pharmaceuticals Private Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Spensus Pharmaceuticals Private Limited

Premium access

GST registrations and filing compliance for Spensus Pharmaceuticals Private Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Spensus Pharmaceuticals Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Spensus Pharmaceuticals Private Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Spensus Pharmaceuticals Private Limited

Premium access

MSME payment history for Spensus Pharmaceuticals Private Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Spensus Pharmaceuticals Private Limited

Premium access

Corporate group structure for Spensus Pharmaceuticals Private Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Spensus Pharmaceuticals Private Limited

Premium access

MCA filings and documents for Spensus Pharmaceuticals Private Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Spensus Pharmaceuticals Private Limited

Activity
30 Sep 2024
Spensus Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Charges
27 Aug 2024
A charge with Sidbi amounted to Rs. 3.48 Cr with Charge ID 100973252 was registered on 27 Aug 2024.
Charges
27 Aug 2024
A charge with Sidbi of Rs. 5.00 Cr registered on 13 Jan 2022 with Charge ID 100533938 was modified on 27 Aug 2024.
Activity
31 Mar 2024
Spensus Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad.
Charges
22 Feb 2022
A charge with Sidbi of Rs. 9.00 Cr registered on 13 Jan 2022 with Charge ID 100532879 was modified on 22 Feb 2022.
Charges
22 Feb 2022
A charge with Sidbi of Rs. 0.50 Cr registered on 13 Jan 2022 with Charge ID 100532868 was modified on 22 Feb 2022.

Frequently Asked Questions about Spensus Pharmaceuticals Private Limited

Spensus Pharmaceuticals Private Limited is an active private limited company in the pharma sector based in Kadi, Gujarat, India. It was incorporated on 24 February 2018 (8+ years old) and is registered under CIN U74999GJ2018PTC100978. The company has 4 employees.

Spensus Pharmaceuticals Private Limited reported revenue of ₹5.59 Cr for FY 2024 (up 48995.00% YoY).

The current directors of Spensus Pharmaceuticals Private Limited are:

The primary industry of Spensus Pharmaceuticals Private Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.

Yes, Spensus Pharmaceuticals Private Limited is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).

Spensus Pharmaceuticals Private Limited can be reached at the registered office: Unit No.1 Survey No.284 BH Honest Hotel Dhanali Road Ahmedabad – Mehsana Highway G, Aneshpura, Kadi, Gujarat, India – 382705, or through the website spensuspharma.com.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available